Morizane Yuki, Kimura Shuhei, Hosokawa Mio, Shiode Yusuke, Hirano Masayuki, Doi Shinichiro, Hosogi Mika, Fujiwara Atsushi, Inoue Yasushi, Shiraga Fumio
Department of Ophthalmology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama, 7008558, Japan.
Inoue Eye Clinic, 1-14-31 Uno, Tamano City, Okayama, 706-0011, Japan.
Jpn J Ophthalmol. 2015 Sep;59(5):279-87. doi: 10.1007/s10384-015-0390-4. Epub 2015 Jul 30.
To evaluate the therapeutic efficacy of a novel surgical procedure for diffuse diabetic macular edema (DME), performed in conjunction with conventional vitrectomy.
This prospective, interventional case series involved 20 eyes of 18 consecutive DME patients with best-corrected visual acuities (BCVAs) between 0.301 and 1.221 logarithm of the minimal angle of resolution (logMAR) units and central retinal thicknesses (CRTs) greater than 275 μm. After vitrectomy, a small retinal detachment was made in the macula by injecting 50-100 μl balanced salt solution into the subretinal space using a 38-gauge needle. Before finishing the surgery, fluid-air exchange was performed. Patients were asked to remain in prone position for 1 day postoperatively. The main outcome measures were CRT and BCVA.
The mean CRT of 554.6 ± 152.7 μm before surgery significantly decreased to 295.6 ± 92.5 μm (p < 0.0001) 1 week after surgery and to 185.8 ± 67.4 μm (p < 0.0001) at 6 months after surgery. The CRT was less than 250 μm in 18 eyes (90 %) at 6 months after surgery. The mean BCVA before surgery (0.706 ± 0.348) significantly improved at 6 months after surgery (0.431 ± 0.392, p < 0.0001). Postoperative BCVAs improved by more than 0.3 logMAR units in 13 eyes (65 %), remained unchanged in six eyes (30 %) and worsened in one eye (5 %). Macular edema recurred in three eyes (15 %) 2 months after surgery.
This novel planned foveal detachment technique facilitated a rapid resolution of DME and contributed to improved visual acuity.
评估一种新型手术方法联合传统玻璃体切除术治疗弥漫性糖尿病性黄斑水肿(DME)的疗效。
本前瞻性、干预性病例系列研究纳入了18例连续的DME患者的20只眼,最佳矫正视力(BCVA)在0.301至1.221最小分辨角对数(logMAR)单位之间,中心视网膜厚度(CRT)大于275μm。玻璃体切除术后,使用38号针头向视网膜下间隙注入50 - 100μl平衡盐溶液,在黄斑区制造一个小的视网膜脱离。手术结束前,进行液 - 气交换。患者术后需俯卧位1天。主要观察指标为CRT和BCVA。
术前平均CRT为554.6±152.7μm,术后1周显著降至295.6±92.5μm(p<0.0001),术后6个月降至185.8±67.4μm(p<0.000)。术后6个月时,18只眼(90%)的CRT小于250μm。术前平均BCVA为(0.706±0.348),术后6个月显著改善(0.431±0.392,p<0.0001)。13只眼(65%)的术后BCVA改善超过0.3 logMAR单位,6只眼(30%)保持不变,1只眼(5%)恶化。术后2个月,3只眼(15%)出现黄斑水肿复发。
这种新型的计划性黄斑脱离技术有助于快速消退DME并提高视力。